Decision-making under uncertainty in advanced heart failure

被引：12

作者：

Meyer T.E. ^{[1
]}

Kiernan M.S. ^{[2
]}

McManus D.D. ^{[1
]}

Shih J. ^{[1
]}

机构：

[1] Department of Medicine, Division of Cardiology, University of Massachusetts Medical Center, Worcester, MA 01655

[2] Department of Medicine, Division of Cardiology, Tufts School of Medicine Tufts Medical Center, Boston, MA 02111

来源：

Current Heart Failure Reports | 2014年 / 11卷 / 2期

关键词：

Advanced heart failure; Decision-making; Decision-making tools; Judgment and bias; Uncertainty;

D O I：

10.1007/s11897-014-0195-7

中图分类号：

学科分类号：

摘要：

The challenges managing advanced heart failure (AHF) are mounting, not least by the presence of multiple coexisting comorbidities, the lack of evidence of clinical benefit in many subsets of AHF, but also surrounding the uncertainty of the both short-term and long-term prognosis. Clinicians are highly variable in their interpretation of clinical data and are prone to considerable bias when it comes to treatment recommendations. This manuscript provides a critical appraisal of the uncertainties as it pertains to the natural history of AHF and management decisions. First, clinical examples are explored to illustrate common errors of judgment due to unrecognized biases. Secondly, a tool is provided that promulgates a structured approach to key data elements in an attempt to create a sound platform for decision-making. © Springer Science+Business Media 2014.

引用

页码：188 / 196

页数：8

共 46 条

[1]

Allen L.A., Stevenson L.W., Grady K.L., Et al., Decision making in advanced heart failure: A scientific statement from the American Heart Association, Circulation, 125, 15, pp. 1928-1952, (2012)

[2]

Tricoci P., Allen J.M., Kramer J.M., Califf R.M., Smith Jr. S.C., Scientific evidence underlying the ACC/AHA clinical practice guidelines, JAMA, 301, 8, pp. 831-841, (2009)

[3]

Bland A.R., Schaefer A., Different varieties of uncertainty in human decision-making, Front Neurosci, 6, pp. 1-11, (2012)

[4]

Loh J.C., Creaser J., Rourke D.A., Livingston N., Et al., Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: Findings from a university referral center, Circ Heart Fail, 6, 3, pp. 411-419, (2013)

[5]

Alba A.C., Agoritsas T., Jankowski M., Courvoisier D., Et al., Risk prediction models for mortality in ambulatory patients with heart failure: A systematic review, Circ Heart Fail, 6, 5, pp. 881-889, (2013)

[6]

Chen C., Stevenson L., Stewart G.C., Et al., Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries, J Am Coll Cardiol, 61, 21, pp. 2142-2150, (2013)

[7]

Habal M.V., Liu P.P., Austin P.C., Et al., Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure, Circ Heart Fail, 7, 1, pp. 12-20, (2014)

[8]

Cleland J.G., Chiswell K., Teerlink J.R., Et al., Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: A report from the placebocontrolled randomized study of the selective A1 Adenosine Receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study, Circ Heart Fail, 7, 1, pp. 76-87, (2014)

[9]

Madan V.D., Novak E., Rich M.W., Impact of change in serumsodium concentration onmortality in patients hospitalized with heart failure and hyponatremia, Circ Heart Fail, 4, 5, pp. 637-643, (2011)

[10]

Kittleson M., Hurwitz S., Shah M.R., Nohria A., Lewis E., Givertz M., Fang J., Jarcho J., Mudge G., Stevenson L.W., Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality, Journal of the American College of Cardiology, 41, 11, pp. 2029-2035, (2003)

← 1 2 3 4 5 →